Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Let's Talk About Financial Toxicities.

Anne Katz1

  • 1CancerCare Manitoba.

Oncology Nursing Forum
|April 24, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moving the Science Forward.

Oncology nursing forum·2025
Same author

Sexuality, sexual function important aspects of survivorship care.

Canadian family physician Medecin de famille canadien·2024
Same author

Procainamide-Provoked Brugada Pattern in a Patient Presenting with New-Onset Atrial Fibrillation or Flutter: When Does it Matter?

The Journal of emergency medicine·2023
Same author

Sexuality After Cancer as an Unmet Need: Addressing Disparities, Achieving Equality.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2022
Same author

Feasibility, Acceptability, and Clinical Significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program (<i>TEMPO</i>) Tailored to the Needs of Men with Prostate Cancer and Their Caregivers: A Multi-Center Randomized Pilot Trial.

Current oncology (Toronto, Ont.)·2022
Same author

Acceptability and Usefulness of a Dyadic, Tailored, Web-Based, Psychosocial and Physical Activity Self-Management Program (TEMPO): A Qualitative Study.

Journal of clinical medicine·2020
Same journal

Exploring Information Needs of Patients With Cancer and Family Caregivers: A Descriptive and Network Analysis of End-of-Life Inquiries.

Oncology nursing forum·2026
Same journal

Postoperative Physiologic Comfort Management for Patients With Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy.

Oncology nursing forum·2026
Same journal

Exploring Racial Disparities in Uterine Cancer Survival: A 20-Year, Single-Site Analysis.

Oncology nursing forum·2026
Same journal

What I See as an Editor: The Reach of Nurse-Led Intervention Oncology Research.

Oncology nursing forum·2026
Same journal

Trends and Hot Spots in Cancer Family Resilience: A Bibliometric and Visualization Study.

Oncology nursing forum·2026
Same journal

Seven-Year Cognitive Trajectories in Older Adult Cancer Survivors: Findings From a National Cohort Study.

Oncology nursing forum·2026
See all related articles

Precision medicine, targeted therapies, and personalized medicine offer advanced treatment options. However, understanding these terms and drug nomenclature presents unique challenges for healthcare professionals.

Area of Science:

  • Oncology
  • Pharmacology
  • Genetics

Background:

  • Precision medicine, targeted therapies, and personalized medicine are rapidly evolving fields.
  • These approaches aim to tailor medical treatment to individual patient characteristics.
  • Confusion often arises from the overlapping terminology and complex drug naming conventions.

Purpose of the Study:

  • To clarify the distinctions between precision medicine, targeted therapies, and personalized medicine.
  • To address the challenges associated with generic and trade drug names in these fields.
  • To enhance understanding and facilitate effective application of these advanced treatment modalities.

Main Methods:

  • Literature review of current definitions and applications.
  • Analysis of common terminology used in scientific conferences and publications.
Keywords:
cancercost of carefinancial toxicityquality of life

Related Experiment Videos

  • Case study examples illustrating drug nomenclature complexities.

    • Main Results:

    • Identified significant overlap and interchangeable use of terms like precision medicine, targeted therapy, and personalized medicine.
    • Highlighted the difficulties in navigating generic versus brand-name drugs for specific targeted therapies.
    • Demonstrated the need for standardized communication regarding these concepts.

    Conclusions:

    • Clearer definitions and consistent terminology are crucial for advancing precision medicine.
    • Addressing drug nomenclature challenges will improve patient safety and treatment efficacy.
    • Further education and resources are needed for healthcare providers to effectively implement these personalized approaches.